The drugs are injectable through the skin or into a vein. The Food and Drug Administration (FDA) has approved the biologic drug dupilumab (Dupixent). Doctors prescribe it for people with moderate ...

Following receipt of dupilumab for 24 weeks, desensitization to peanut exposure in most children/adolescents with peanut allergy was not achieved, according to study results. Image: Adobe Stock ...

KT-621 is an investigational first-in-class once-daily, oral STAT6 degrader with dupilumab-like activity ... biologics with the convenience of oral administration, which, in turn, can transform ...